SEARCH

SEARCH BY CITATION

References

  • Bahia P. K., Rattray M. and Williams R. J. (2008) Dietary flavonoid (-)epicatechin stimulates phosphatidylinositol 3-kinase-dependent anti-oxidant response element activity and up-regulates glutathione in cortical astrocytes. J. Neurochem. 106, 21942204.
  • Bannai S. (1986) Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J. Biol. Chem. 261, 22562263.
  • Bogdanov M. B., Andreassen O. A., Dedeoglu A., Ferrante R. J. and Beal M. F. (2001) Increased oxidative damage to DNA in a transgenic mouse model of Huntington’s disease. J. Neurochem. 79, 12461249.
  • Bruijn L. I., Miller T. M. and Cleveland D. W. (2004) Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 27, 723749.
  • Burdo J., Dargusch R. and Schubert D. (2006) Distribution of the cystine/glutamate antiporter system xc- in the brain, kidney, and duodenum. J. Histochem. Cytochem. 54, 549557.
  • Chi L., Ke Y., Luo C., Gozal D. and Liu R. (2007) Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo. Neuroscience 144, 9911003.
  • Choi D. W. (1992) Excitotoxic cell death. J. Neurobiol. 23, 12611276.
  • Chu K., Lee S. T., Sinn D. I. et al. (2007) Pharmacological induction of ischemic tolerance by glutamate transporter-1 (EAAT2) upregulation. Stroke 38, 177182.
  • Clement A. M., Nguyen M. D., Roberts E. A. et al. (2003) Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302, 113117.
  • Davis J. B. and Maher P. (1994) Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line. Brain Res. 652, 169173.
  • Dringen R. (2000) Glutathione metabolism and oxidative stress in neurodegeneration. Eur. J. Biochem. 267, 4903.
  • Dringen R. and Hirrlinger J. (2003) Glutathione pathways in the brain. Biol. Chem. 384, 505516.
  • Fogal B., Li J., Lobner D., McCullough L. D. and Hewett S. J. (2007) System x(c)- activity and astrocytes are necessary for interleukin-1 beta-mediated hypoxic neuronal injury. J. Neurosci. 27, 1009410105.
  • Fox J. H., Barber D. S., Singh B. et al. (2004) Cystamine increases L-cysteine levels in Huntington’s disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation. J. Neurochem. 91, 413422.
  • Gurney M. E., Pu H., Chiu A. Y. et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 17721775.
  • Hanneken A., Lin F. F., Johnson J. and Maher P. (2006) Flavonoids protect human retinal pigment epithelial cells from oxidative-stress-induced death. Invest. Ophthalmol. Vis. Sci. 47, 31643177.
  • Hosoya K., Saeki S. and Terasaki T. (2001) Activation of carrier-mediated transport of L-cystine at the blood-brain and blood-retinal barriers in vivo. Microvasc. Res. 62, 136142.
  • Ishii T., Itoh K., Takahashi S., Sato H., Yanagawa T., Katoh Y., Bannai S. and Yamamoto M. (2000) Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J. Biol. Chem. 275, 1602316029.
  • Karumbayaram S., Kelly T. K., Paucar A. A., Roe A. J., Umbach J. A., Charles A., Goldman S. A., Kornblum H. I. and Wiedau-Pazos M. (2009) Human embryonic stem cell-derived motor neurons expressing SOD1 mutants exhibit typical signs of motor neuron degeneration linked to ALS. Dis. Model Mech. 2, 189195.
  • Kensler T. W., Wakabayashi N. and Biswal S. (2007) Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 47, 89116.
  • Kirby J., Halligan E., Baptista M. J. et al. (2005) Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS. Brain 128, 16861706.
  • Krobert K., Lopez-Colberg I. and Cunningham L. A. (1997) Astrocytes promote or impair the survival and function of embryonic ventral mesencephalon co-grafts: effects of astrocyte age and expression of recombinant brain-derived neurotrophic factor. Exp. Neurol. 145, 511523.
  • Lewerenz J. and Maher P. (2009) Basal levels of eIF2alpha phosphorylation determine cellular antioxidant status by regulating ATF4 and xCT expression. J. Biol. Chem. 284, 11061115.
  • Lewerenz J., Letz J. and Methner A. (2003) Activation of stimulatory heterotrimeric G proteins increases glutathione and protects neuronal cells against oxidative stress. J. Neurochem. 87, 522531.
  • Lewerenz J., Klein M. and Methner A. (2006) Cooperative action of glutamate transporters and cystine/glutamate antiporter system Xc protects from oxidative glutamate toxicity. J. Neurochem. 98, 916925.
  • Lipski J., Wan C. K., Bai J. Z., Pi R., Li D. and Donnelly D. (2007) Neuroprotective potential of ceftriaxone in in vitro models of stroke. Neuroscience 146, 617629.
  • Maher P. (2006) A comparison of the neurotrophic activities of the flavonoid fisetin and some of its derivatives. Free Radic. Res. 40, 11051111.
  • Maher P. and Davis J. B. (1996) The role of monoamine metabolism in oxidative glutamate toxicity. J. Neurosci. 16, 63946401.
  • Maher P. and Hanneken A. (2005) The molecular basis of oxidative stress-induced cell death in an immortalized retinal ganglion cell line. Invest. Ophthalmol. Vis. Sci. 46, 749757.
  • Melzer N., Meuth S. G., Torres-Salazar D. et al. (2008) A beta-lactam antibiotic dampens excitotoxic inflammatory CNS damage in a mouse model of multiple sclerosis. PLoS ONE 3, e3149.
  • Miller B. R., Dorner J. L., Shou M., Sari Y., Barton S. J., Sengelaub D. R., Kennedy R. T. and Rebec G. V. (2008) Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington’s disease phenotype in the R6/2 mouse. Neuroscience 153, 329337.
  • Miyamoto M., Murphy T. H., Schnaar R. L. and Coyle J. T. (1989) Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. J. Pharmacol. Exp. Ther. 250, 11321140.
  • Murphy T. H., Miyamoto M., Sastre A., Schnaar R. L. and Coyle J. T. (1989) Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2, 15471558.
  • Murphy T. H., Schnaar R. L. and Coyle J. T. (1990) Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake. FASEB J. 4, 16241633.
  • Nau R., Prange H. W., Muth P., Mahr G., Menck S., Kolenda H. and Sorgel F. (1993) Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges. Antimicrob. Agents Chemother. 37, 15181524.
  • Nguyen T., Sherratt P. J. and Pickett C. B. (2003) Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu. Rev. Pharmacol. Toxicol. 43, 233260.
  • Ouyang Y. B., Voloboueva L. A., Xu L. J. and Giffard R. G. (2007) Selective dysfunction of hippocampal CA1 astrocytes contributes to delayed neuronal damage after transient forebrain ischemia. J. Neurosci. 27, 42534260.
  • Oyama Y., Hayashi A., Ueha T. and Maekawa K. (1994) Characterization of 2′,7′-dichlorofluorescin fluorescence in dissociated mammalian brain neurons: estimation on intracellular content of hydrogen peroxide. Brain Res. 635, 113117.
  • Poon H. F., Hensley K., Thongboonkerd V., Merchant M. L., Lynn B. C., Pierce W. M., Klein J. B., Calabrese V. and Butterfield D. A. (2005) Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice–a model of familial amyotrophic lateral sclerosis. Free Radic. Biol. Med. 39, 453462.
  • Ratan R. R., Murphy T. H. and Baraban J. M. (1994) Oxidative stress induces apoptosis in embryonic cortical neurons. J. Neurochem. 62, 376379.
  • Re R., Pellegrini N., Proteggente A., Pannala A., Yang M. and Rice-Evans C. (1999) Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic. Biol. Med. 26, 12311237.
  • Rimaniol A. C., Mialocq P., Clayette P., Dormont D. and Gras G. (2001) Role of glutamate transporters in the regulation of glutathione levels in human macrophages. Am. J. Physiol. Cell Physiol. 281, C1964C1970.
  • Rothstein J. D., Van Kammen M., Levey A. I., Martin L. J. and Kuncl R. W. (1995) Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38, 7384.
  • Rothstein J. D., Patel S., Regan M. R. et al. (2005) Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433, 7377.
  • Rumbaugh J. A., Li G., Rothstein J. and Nath A. (2007) Ceftriaxone protects against the neurotoxicity of human immunodeficiency virus proteins. J. Neurovirol. 13, 168172.
  • Sasaki H., Sato H., Kuriyama-Matsumura K. et al. (2002) Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. J. Biol. Chem. 277, 4476544771.
  • Sato H., Tamba M., Ishii T. and Bannai S. (1999) Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J. Biol. Chem. 274, 1145511458.
  • Sato H., Shiiya A., Kimata M. et al. (2005) Redox imbalance in cystine/glutamate transporter-deficient mice. J. Biol. Chem. 280, 3742337429.
  • Schluter K., Figiel M., Rozyczka J. and Engele J. (2002) CNS region-specific regulation of glial glutamate transporter expression. Eur. J. Neurosci. 16, 836842.
  • Schulz J. B., Lindenau J., Seyfried J. and Dichgans J. (2000) Glutathione, oxidative stress and neurodegeneration. Eur. J. Biochem. 267, 49044911.
  • Sheldon A. L. and Robinson M. B. (2007) The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem. Int. 51, 333355.
  • Shih A. Y., Johnson D. A., Wong G., Kraft A. D., Jiang L., Erb H., Johnson J. A. and Murphy T. H. (2003) Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J. Neurosci. 23, 33943406.
  • Shih A. Y., Erb H., Sun X., Toda S., Kalivas P. W. and Murphy T. H. (2006) Cystine/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation. J. Neurosci. 26, 1051410523.
  • Sun X., Shih A. Y., Johannssen H. C., Erb H., Li P. and Murphy T. H. (2006) Two-photon imaging of glutathione levels in intact brain indicates enhanced redox buffering in developing neurons and cells at the cerebrospinal fluid and blood-brain interface. J. Biol. Chem. 281, 1742017431.
  • Swanson R. A., Liu J., Miller J. W., Rothstein J. D., Farrell K., Stein B. A. and Longuemare M. C. (1997) Neuronal regulation of glutamate transporter subtype expression in astrocytes. J. Neurosci. 17, 932940.
  • Tan S., Schubert D. and Maher P. (2001) Oxytosis: a novel form of programmed cell death. Curr. Top. Med. Chem. 1, 497506.
  • Tomizawa S., Imai H., Tsukada S. et al. (2005) The detection and quantification of highly reactive oxygen species using the novel HPF fluorescence probe in a rat model of focal cerebral ischemia. Neurosci. Res. 53, 304313.
  • Urushitani M., Ezzi S. A. and Julien J. P. (2007) Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 104, 24952500.
  • Wang W. and Jaiswal A. K. (2006) Nuclear factor Nrf2 and antioxidant response element regulate NRH:quinone oxidoreductase 2 (NQO2) gene expression and antioxidant induction. Free Radic. Biol. Med. 40, 11191130.
  • Zargari M., Allameh A., Sanati M. H., Tiraihi T., Lavasani S. and Emadyan O. (2007) Relationship between the clinical scoring and demyelination in central nervous system with total antioxidant capacity of plasma during experimental autoimmune encephalomyelitis development in mice. Neurosci. Lett. 412, 2428.